Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mole Genetics
Lysaker, Norway
- Ownership
- Private
- Development stage
- Other
01
Overview
Mole Genetics AS was a Norwegian biotechnology company that specialized in automated nucleic acid extraction technology. Based in Lysaker, the company developed the GeneMole® system, a compact benchtop instrument designed to automate the isolation of DNA and RNA from various biological samples using its proprietary MoleStrips™ technology. The system was designed to simplify laboratory workflows by providing pre-filled, ready-to-use reagent strips, reducing hands-on time and improving consistency in genetic research and diagnostics. In 2008, Mole Genetics was acquired by Qiagen, which integrated the GeneMole technology into its global portfolio of sample preparation solutions.
- Modalities
- Device
- Industry
- Molecular Diagnostics
Beyond the preview
Go deeper on Mole Genetics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mole Genetics.